Activation of P38MAPK signaling cascade in a VSMC injury model: Role of P38MAPK inhibitors in limiting VSMC proliferation

European Journal of Vascular and Endovascular Surgery

Volumn 29, Issue 5, 2005, Pages 470-478

  Jacob, T ^a   Ascher, Enrico ^a   Alapat, D ^a   Olevskaia, Y ^a   Hingorani, A ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

Activation; p38MAPK; VSMC

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 ETHYL 2 (4 METHOXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 (2 AMINO 4 PYRIMIDINYL) 4 (4 FLUOROPHENYL) 1 (4 PIPERIDINYL)IMIDAZOLE; ENZYME ACTIVATOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL DAMAGE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CULTURE MEDIUM; CYTOTOXICITY; DISEASE MODEL; DRUG ANTAGONISM; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INJURY SCALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; IMIDAZOLES; MUSCLE, SMOOTH, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; PYRIMIDINES;

EID: 22144462493     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2005.01.030     Document Type: Article

References (21)

1. J. Han J.D. Lee L. Bibbs R.J. Ulevitch A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells Science 265 5173 1994 808-811
2. J.C. Lee J.T. Laydon P.C. McDonnell T.F. Gallagher S. Kumar D. Green et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nature 372 6508 1994 739-746
3. L. New J. Han The p38 MAP kinase pathway and its biological function Trends Cardiovasc Med 1998 8220-8229
4. D. Bokemeyer M. Lindemann H.J. Kramer Regulation of mitogen-activated protein kinase phosphatase-1 in vascular smooth muscle cells Hypertension 32 1998 661-667
5. M. Karin Mitogen-activated protein kinase cascades as regulators of stress responses Ann N Y Acad Sci 851 1998 139-146
6. N. Begum L. Ragolia High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNos via p38 MAPK activation Am J Physiol Cell Physiol 278 2000 C81-C91
7. H. Ohashi A. Matsumori Y. Furukawa K. Ono M. Okada A. Iwasaki et al. Role of p38 mitogen activated protein kinase in neointimal hyperplasia after vascular injury Arterioscler Thromb Vasc Biol 20 2000 2521-2526
8. T. Yamakawa S. Eguchi T. Matsumoto Y. Yamakawa K. Numaguchi I. Miyata et al. Intracellular signaling in rat cultured vascular smooth muscle cells: Roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production Endocrinology 140 8 1999 3562-3572
9. C. Garat V. Van Putten Z.A. Refaat C. Dessev S.Y. Han R.A. Nemenoff Induction of smooth muscle alpha-actin in vascular smooth muscle cells by arginine vasopressin is mediated by c-Jun amino-terminal kinases and p38 mitogen-activated protein kinase J Biol Chem 275 29 2000 22537-22543
10. J.R. Jackson B. Bolognese L. Hillegass S. Kassis J. Adams D.E. Griswold et al. Pharmacological effects of SB220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models J Pharmacol Exp Ther 284 2 1997 687-692
11. M. Scheinman E. Ascher S. Kallakuri A. Hingorani P. Gade M. Sherman et al. P53 gene transfer to the injured rat carotid artery promotes apoptosis Surgery 126 1999 863-868
12. M. Igarash H. Yamaguchi A. Hirata M. Daimon M. Tominaga T. Kato Insulin activates p38 mitogen-activated protein (MAP) kinase via a MAP kinase kinase (MKK) 3/MKK 6 pathway in vascular smooth muscle cells Eur J Clin Invest 30 8 2000 668-677
13. O. Casanovas F. Miro J.M. Estanyol E. Itarte N. Agell O. Bachs Osmotic stress regulates the stability of cyclin D1 in a p38SAPK2-dependent manner J Biol Chem 275 45 2000 35091-35097
14. Z. Guan S.Y. Buckman A.P. Pentlands D.J. Templeton A.R. Morrison Induction of cyclooxygenase-2 by the activated MEKK1→SEK1/ MKK4→p38 mitogen-activated protein kinase pathway J Biol Chem 273 21 1998 12901-12908
15. J. Guay H. Lambert G. Gingras-Breton J.N. Lavoie J. Hout J. Landry Regulation of actin filaments dynamics by p38 MAP kinase-mediated phosphorylation of heat shock protein 27 J Cell Sci 110 1997 357-368
16. J.C. Hedges M.A. Decher I.A. Yamboliev J.L. Martin E. Hickey L.A. Weber et al. A role for p38MAPK/HSP27 in smooth muscle cell migration J Biol Chem 274 34 1999 2411-2419
17. X.A. Li C. Bianchi F.W. Sellke Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB J Surg Res 100 2 2001 197-204
18. D. Zechner R. Craig D.S. Hanford P.M. McDonough R.A. Sabbadini C.C. Glembotski MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner J Biol Chem 273 14 1998 8232-8239
19. J.L. Kummer P.K. Rao K.A. Heidenreich Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase J Biol Chem 272 33 1997 20490-20494
20. K. Mackay D. Mochly-Rosen An inhibitor of p38 mitogen activated protein kinase protects neonatal cardiac myocytes from ischemia J Biol Chem 274 10 1999 6272-6279
21. A.S. Zervos L. Faccio J.P. Gatto J.M. Kyriakis R. Brent Mxi2, a mitogen-activated protein kinase that recognizes and phosphorylates Max protein Proc Natl Acad Sci U S A 92 23 1995 10531-10534